Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

St. Jude Medical Acquires Endosense - Quick Facts

RELATED NEWS
Trade STJ now with 

St. Jude Medical Inc. (STJ: Quote) announced the acquisition of Endosense SA, a Switzerland-based medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias. St. Jude Medical has made an initial payment of approximately $170 million, and acquired 100 percent of the outstanding equity of Endosense. The terms also provide for an additional cash payment of up to $161 million, which is contingent upon both the achievement and timing of a regulatory milestone.

St. Jude Medical said, except for acquisition-related expenses, the deal does not impact its outlook for 2013 consolidated earnings per share.

Click here to receive FREE breaking news email alerts for St. Jude Medical Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Policymakers of Reserve Bank of Australia decided to maintain its record low interest rate once again as they continue to assess that the most prudent course is a period of stability in interest rates. The monetary policy board retained the cash rate at 2.50 percent. The rate has been at the current level since August 2013. A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed Monday. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.